EUVIMEDEUVIMED entdecken
Crossref

Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function

Zhiqiang Ren, Yinyin Xue, Liang Liu, Xuesai Zhang, Jinpeng Pei, Yu Zhang, Yue Wang, Ker Yu

Cancer Letters · 2023-07 · 565 · 216221

DOI: 10.1016/j.canlet.2023.216221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023-07. Verfasst von Zhiqiang Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Fudan University School of Pharmacy, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) remains a most deadly human malignancy with limited response to chemotherapy, targeted therapy and immunotherapy. Tumor immunoenvironment plays an increasingly important role in therapy outcome. Tissue factor (TF) is the target of the FDA-approved ADC Tivdak. HuSC1-39 is the parent antibody of MRG004A, a clinical stage TF-ADC (NCT04843709). Here, we employed HuSC1-39 (termed "anti-TF") to investigate the role of TF in regulating immune-tolerance in TNBC. We found that patients with aberrant TF expression had a poor prognosis and low immune effector cell infiltration, characterizing as "cold tumor". In the 4T1 TNBC syngeneic mouse model, knockout of tumor cell TF inhibited tumor growth and increased tumor infiltration of effector T cell, which was not dependent on the clotting inhibition. In an immune-reconstituted M-NSG mouse model of TNBC, anti-TF inhibited tumor growth, which was further enhanced by a dual-targeting anti-TF&TGFβR fusion protein. There were diminished P-AKT and P-ERK signaling and profound tumor cell death in treated tumors. Transcriptome analyses and immunohistochemistry revealed a dramatically improved tumor immunoenvironment including the increase of effector T cells, decrease of Treg cells and the transformation of tumor into "hot tumor". Moreover, employing qPCR analysis and T cell culture, we further demonstrated that TF expression in tumor cells is sufficient to block the synthesis and secretion of T cell-recruiting chemokine CXCL9/10/11. Treatment of TF-high TNBC cells with anti-TF or TF-knockout all stimulated CXCL9/10/11 production, promoted T cell migration and effector function. Thus, we have identified a new mechanism of TF in TNBC tumor progression and therapy resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsAnimalsMiceHumansThromboplastinImmune EvasionSignal TransductionImmunotherapyCell Line, Tumor

Stichwörter der Autor:innen

ChemokineCytotoxic T cellTGFβTNBCTissue factor

Substanzen

Thromboplastin

Autor:innen und Institutionen

  • Department of Pharmacology, Fudan University School of Pharmacy, Shanghai, 201203, China.
  • Department of Pharmacology, Fudan University School of Pharmacy, Shanghai, 201203, China. Electronic address: keryu@fudan.edu.cn.

Zitieren

APA

Ren, Z., Xue, Y., Liu, L., Zhang, X., Pei, J., Zhang, Y., Wang, Y., & Yu, K. (2023). Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function. Cancer Letters, 565, 216221. https://doi.org/10.1016/j.canlet.2023.216221

Vancouver

Ren Z, Xue Y, Liu L, Zhang X, Pei J, Zhang Y, et al. Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function. Cancer Letters. 2023;565:216221. doi:10.1016/j.canlet.2023.216221

BibTeX
@article{Ren2023,
  author = {Ren, Zhiqiang and Xue, Yinyin and Liu, Liang and Zhang, Xuesai and Pei, Jinpeng and Zhang, Yu and Wang, Yue and Yu, Ker},
  title = {Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function},
  journal = {Cancer Letters},
  year = {2023},
  volume = {565},
  pages = {216221},
  doi = {10.1016/j.canlet.2023.216221}
}
Kostenlos starten →